Real-time enrollment status for this nash cirrhosis clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 1:53 PM UTC
| NCT Number | NCT06632457 |
| Recruiting Status | Recruiting |
| Condition | NASH Cirrhosis |
| Phase | PHASE3 |
| Target Enrollment | 1,590 participants |
| Active Locations | 126 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | October 14, 2026 (Yesterday) |
As of October 15, 2026: Clinical trial NCT06632457 is currently recruiting participants. This phase3 study for nash cirrhosis is actively seeking new participants at 126 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06632457 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 126 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06632457 was last updated Yesterday (October 14, 2026). HelloStudys verifies this status automatically.